Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 572,220 shares at $20.74 ($11.9M) on 2024-07-03, disclosed to the SEC on 2024-07-08.
Scheduled sale ($11.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.69 | 144,444 | $3.0M | 25.2% |
| 2 | $20.69 | 144,444 | $3.0M | 25.2% |
| 3 | $20.74 | 94,444 | $2.0M | 16.5% |
| 4 | $20.74 | 94,444 | $2.0M | 16.5% |
| 5 | $20.75 | 94,444 | $2.0M | 16.5% |
| Total | $20.72 avg | 572,220 |
| $11.9M |
| 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |